ArticleCancer discovery2025

Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers.

Giulia Montuori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.